High PD-L1 expression is associated with a poor prognosis in solid tumors, including lung, ovarian or colon cancer, thus supporting the impressive results that PD-1/PD-L1 blockade has led in several cancers (36). This evidence concerns the gene CD274 and malignant colon neoplasm.